ALBUQUERQUE, N.M.--(BUSINESS WIRE)-- WaveFront Sciences Inc. (WaveDyn™), an early stage ophthalmic medical device company, today announced that Jeff Kolberg has been appointed as the company’s Chief Commercial Officer (CCO). Mr. Kolberg joins the leadership team with extensive industry experience to lead WaveDyn’s corporate strategy and future commercialization of its products, including overseeing marketing, sales and service teams. The company is focusing efforts on its dynamic wavefront measurement device and advanced treatment solutions, which will help restore vision and quality of life for patients with highly aberrated eyes.

“We are absolutely delighted to welcome Jeff to the WaveDyn team. He brings more than 20 years of medical device business experience with more than a decade of developing and commercializing ophthalmology products, including wavefront diagnostic devices, on a global basis,” said Dan Neal, CEO. “I’ve known and worked closely with Jeff for more than 10 years at the same industry-leading ophthalmic organizations. His unique, in-depth understanding of WaveDyn’s technology, coupled with his commercial experience and comprehensive understanding of the vision care industry makes Jeff a true asset for our current and future business needs.”

Before joining WaveDyn, Mr. Kolberg spent ten years working for Johnson & Johnson Vision and Abbott Medical Optics. Most recently, at Johnson & Johnson Vision, he was responsible for global marketing and commercialization of a portfolio of premium intraocular lenses. At Abbott Medical Optics, he led global commercialization for the iDesign System and was a recipient of a divisional President’s award for his achievements. Previously, Mr. Kolberg had worked for Abbott’s Vascular and Diagnostics divisions in both global and U.S. commercial roles with escalating responsibility. He has a bachelor’s degree in biological science and earned a Master of Business Administration (MBA) with an emphasis in healthcare from the University of California, Irvine.

“It has been an honor to work in the vision care industry and witness firsthand the profound effect that restoring one’s vision has on improving one’s quality of life,” said Mr. Kolberg. “I look forward to leveraging my industry knowledge and experience to bring WaveDyn to the forefront of providing innovative solutions that benefit both patients and eye care practitioners alike.”

About WaveFront Dynamics Inc.

Founded in 2019, WaveFront Dynamics Inc. (WaveDyn) is a privately held, early-stage medical device company with innovative wavefront diagnostic technology for use in the vision care industry. The company plans to leverage the dynamic measurements to yield new insights into assessing visual performance, advancing treatment options, and improving quality of life for the visually impaired. For more information, please visit www.wavedyn.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200812005474/en/